Vascular endothelial growth inhibitor (VEGI) is an endothelial cell‐specific cytokine and a
potent inhibitor of endothelial cell proliferation and angiogenesis. The role of VEGI in …

ABSTRACT A novel member of the tumor necrosis factor (TNF) family has been identified
from the human umbilical vein endothelial cell cDNA library, named vascular endothelial …

Revascularization of damaged tissue is a necessary part of wound healing. With
unregulated or insufficient vessel growth, healing is delayed or pathological. Angiogenesis …

Vascular endothelial cell growth inhibitor (VEGI), a member of the tumor necrosis factor
(TNF) family, is an endothelial cell‐specific inhibitor of angiogenesis. Overexpression by …

Recently, we reported a novel protein of the tumor necrosis factor (TNF) superfamily, named
vascular endothelial cell growth inhibitor (VEGI), which is expressed predominantly in …

BACKGROUND: A chronic wound is tissue with an impaired ability to heal. This is often a
consequence of one of the following etiologies: diabetes, venous reflux, arterial insufficiency …

VEGI (vascular endothelial cell growth inhibitor) is a novel cytokine which belongs to the
TNF super-family. In this study, the VEGI gene from ECV304 cells was cloned. A truncated …

Angiogenesis is a critical step of wound healing, and its failure leads to chronic wounds. The
idea of restoring blood flow to the damaged tissues by promoting neo-angiogenesis is …

Significance: Angiogenesis, the growth of new blood vessels from existing vessels, is an
important aspect of the repair process. Restoration of blood flow to damaged tissues …

The objective of this study is to investigate the characteristics of the recombinant variant of
human vascular endothelial cell growth inhibitor, VEGI72–251, and compare its biological …